Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Surgalign logo — Global medical technology company focused on elevating the s...

Surgalign

Global medical technology company focused on elevating the standard of care by driving the evolution of digital health.

Founded 2020 United States Deerfield, United States 36 employees Post-IPO Equity Total: $50.00M Biotechnology, Health Care

General Information

Company Name Surgalign
Founded Year 2020
Location United States Deerfield, United States
Founders / Decision Makers
Team member
Employees 36
Industries Biotechnology, Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Surgalign. To contact Surgalign, visit surgalign.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Surgalign compare?

A PDF of Surgalign and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Surgalign soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Surgalign

Surgalign Holdings, Inc. is a global medical technology company committed to driving the evolution of digital health, with a slogan that emphasizes elevating the standard of care. Founded in 1998, Surgalign is focused on advancing the standard of care through the development of innovative technologies. The company markets its products throughout the United States and in approximately 50 countries worldwide through a network of top independent distributors. Its headquarters is located in Deerfield, IL, with commercial, innovation, and design centers in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Surgalign recently secured a $50.00M post-IPO equity investment on 28 January 2021 to further its mission. With its commitment to digital health and its global presence in the biotechnology and healthcare industries, Surgalign presents a promising opportunity for venture capital investments looking to shape the future of medical technology. For more information, visit www.surgalign.com.

Business keywords: digital health, spine care, surgical solutions, clinical outcomes, economic outcomes, innovation, spine devices, surgical devices, augmented reality, global presence, independent distributors

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $50.00M -
28 Jan 2021

Surgalign Alternatives & Competitors

View All Alternatives
Surgalign vs
TissueLink Medical
TissueLink Medical

Pioneering global medical technology since 1999, delivering advanced energy devices for versatile su...

Venture round
14 employees
Biotechnology, Health Care
Surgalign vs
Vycor Medical, Inc.
Vycor Medical, Inc. United States

Targeting Solutions in Neurosurgery

Post-IPO Equity
10 employees
Biotechnology, Hardware
Compare Surgalign vs Vycor Medical, Inc.
Surgalign vs
NuVasive Clinical Services
NuVasive Clinical Services United States

The nation’s leading provider of intraoperative neuromonitoring services to surgeons and healthcare...

Post-IPO Equity
222 employees
Biotechnology, Health Care
View all alternatives

FAQ About Surgalign

Global medical technology company focused on elevating the standard of care by driving the evolution of digital health.
Surgalign was founded in 2020.
Surgalign is headquartered in Deerfield, United States.
Surgalign operates in Biotechnology and Health Care. Its work centres on digital health, spine care, surgical solutions and clinical outcomes.
Surgalign has approximately 36 employees.
Surgalign has completed 1 funding round, raising a total of $50.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Surgalign include TissueLink Medical, Vycor Medical, Inc., NuVasive Clinical Services, Mazor Robotics, YourAnastomosis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Surgalign and TissueLink Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Surgalign, https://bouncewatch.com/company/surgalign, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout